AI Summary

Research published in Cancer Letters indicates that loss of the tumor suppressor NF1 connects resistance to therapy with a heightened ability of estrogen‑receptor‑positive breast cancer to metastasize to bone. The authors propose that aligning patients’ NF1 status with existing approved treatments could potentially lower the rate of bone metastases.

AI summaries can be wrong sometimes—always verify important details using the source article.